ArticleAntimicrobial agents and chemotherapy2008

Mechanism of action of the antibiotic NXL101, a novel nonfluoroquinolone inhibitor of bacterial type II topoisomerases.

Michael T Black et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.